Cargando…
Discovery of Leishmania Druggable Serine Proteases by Activity-Based Protein Profiling
Leishmaniasis are a group of diseases caused by parasitic protozoa of the genus Leishmania. Current treatments are limited by difficult administration, high cost, poor efficacy, toxicity, and growing resistance. New agents, with new mechanisms of action, are urgently needed to treat the disease. Alt...
Autores principales: | Porta, Exequiel O. J., Isern, Jaime A., Kalesh, Karunakaran, Steel, Patrick G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335491/ https://www.ncbi.nlm.nih.gov/pubmed/35910377 http://dx.doi.org/10.3389/fphar.2022.929493 |
Ejemplares similares
-
Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023) -
Activity-based protein profiling: A graphical review
por: Porta, Exequiel O.J., et al.
Publicado: (2023) -
A BONCAT-iTRAQ method enables temporally resolved quantitative profiling of newly synthesised proteins in Leishmania mexicana parasites during starvation
por: Kalesh, Karunakaran, et al.
Publicado: (2019) -
Serine proteases profiles of Leishmania (Viannia) braziliensis clinical isolates with distinct susceptibilities to antimony
por: Zabala-Peñafiel, Anabel, et al.
Publicado: (2021) -
Quantitative Proteomics Reveals that Hsp90 Inhibition Dynamically Regulates Global Protein Synthesis in Leishmania mexicana
por: Kalesh, Karunakaran, et al.
Publicado: (2021)